Search

Displaying results 9101 - 9110 of 10000 in total
  1. Drug

    RUTI® Vaccine

    go.drugbank.com/drugs/DB15853
    Investigational

    The vaccine has demonstrated a reasonable safety profile and potent stimulation of the immune response against tuberculosis. … Sponsored by Fundació Institut Germans Trias i Pujol, the RUTI® Vaccine is being tested for prevention of COVID-19 infection in a controlled trial with 315 healthcare worker participants (NCT04453488).

  2. Drug

    Denenicokin

    go.drugbank.com/drugs/DB12908
    Investigational

    Denenicokin is under investigation in clinical trial NCT01152788 (Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma).

  3. Drug

    Xanthium strumarium var. canadense pollen

    go.drugbank.com/drugs/DB10462
    Approved

    Xanthium strumarium var. canadense pollen is the pollen of the Xanthium strumarium var. canadense plant. Xanthium strumarium var. canadense pollen is mainly used in allergenic testing.

  4. Drug

    Populus balsamifera subsp. trichocarpa pollen

    go.drugbank.com/drugs/DB10754
    Approved

    Populus balsamifera subsp. trichocarpa pollen is the pollen of the Populus balsamifera subsp. trichocarpa plant. Populus balsamifera subsp. trichocarpa pollen is mainly used in allergenic testing.

  5. Drug

    Lolium perenne subsp. multiflorum pollen

    go.drugbank.com/drugs/DB10964
    Approved

    Lolium perenne subsp. multiflorum pollen is the pollen of the Lolium perenne subsp. multiflorum plant. Lolium perenne subsp. multiflorum pollen is mainly used in allergenic testing.

  6. Drug

    Firmonertinib

    go.drugbank.com/drugs/DB16087
    Investigational

    Alflutinib is under investigation in clinical trial NCT03452592 (Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients With T790M).

  7. Drug

    Indatuximab ravtansine

    go.drugbank.com/drugs/DB16195
    Investigational

    Indatuximab ravtansine is under investigation in clinical trial NCT01001442 (Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma).

  8. Drug

    Mebhydrolin

    go.drugbank.com/drugs/DB13808
    Investigational

    Mebhydrolin is an antihistamine agent.[A275123]

  9. Drug

    Ethylhexylglycerin

    go.drugbank.com/drugs/DB14557
    Investigational

    An emollient solvent with antimicrobial activity.

  10. Drug

    Plamotamab

    go.drugbank.com/drugs/DB18944
    Investigational

    Plamotamab is under investigation in clinical trial NCT05328102 (Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (